This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 4460783 results found since Jan 2013.
A cold spot compensation technique using a combination of trans-rectal ultrasonography and intraoperative computed tomography for interstitial permanent prostate brachytherapy: a single-arm prospective trial.
Conclusion: The cold spot compensation technique using TRUS-CT fusion appears effective for patients receiving permanent interstitial prostate brachytherapy.
PMID: 29619051 [PubMed]
Source: Journal of Contemporary Brachytherapy - April 7, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer.
Conclusions: HDR-BT and LDR-BT for low and intermediate risk prostate cancer had similar PB rate. The PB occurred earlier after HDR-BT than after LDR-BT. ADT and higher Gleason score decreased, and higher PSA nadir and longer time to PSA nadir increased the risk of PB after HDR-BT.
PMID: 29619050 [PubMed]
Source: Journal of Contemporary Brachytherapy - April 7, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer.
Conclusions: The use of a hydrogel prior to salvage HDR-BT in a patient previously treated with HDR-BT is feasible and could help reduce the rectal exposure in the salvage setting.
PMID: 29789766 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 27, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.
Conclusions: LDR brachytherapy is an effective treatment option in low- to intermediate-risk prostate cancer patients. We observed low biochemical relapse rates and minimal GU toxicities several years after treatment in patients with or without TURP. However, a small risk of urinary retention was observed in some patients.
PMID: 29789764 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 27, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Verification of high-dose-rate brachytherapy treatment planning dose distribution using liquid-filled ionization chamber array.
Conclusion: The dosimetric properties of IA 2.5-5 mm showed the applicability of liquid-filled ionization chamber array as a potential QA device for HDR brachytherapy treatment planning systems.
PMID: 29789763 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 27, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma.
Conclusions: VBT alone is as effective as EBRT+VBT in ensuring loco-regional control and achieving comparable survival rates, with fewer toxic effects for patients with stage I intermediate- and high-risk endometrial carcinoma. The dose escalation did not make a difference in the survival rates and was like in the other major trials (PORTEC-2).
PMID: 29789759 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 27, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Advantages of intraoperative implant for interstitial brachytherapy for accelerated partial breast irradiation either frail patients with early-stage disease or in locally recurrent breast cancer.
Conclusions: This technique, although time-consuming, achieves good local disease control with a satisfactory toxicity profile in both early-stage and local recurrent breast cancer patients. It may be especially suitable for frail patients.
PMID: 29789758 [PubMed]
Source: Journal of Contemporary Brachytherapy - May 27, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report.
Authors: Rospond-Kubiak I, Adamski W, Sosnowska K, Kociȩcki J, Marszałek A
Abstract
The aim of this study is to report the use of ruthenium brachytherapy as an adjunctive treatment in the management of an intraocular extension of the conjunctival squamous cell carcinoma (SCC). In 2013, a 73-year-old man presented with a tumor blocking the angle and infiltrating corneal endothelium. The patient was treated with iridectomy, and after one month, ruthenium brachytherapy was applied. 4.5 years post-irradiation, the treated eye is painless, and no recurrence was noted. We advocate the use of ruthenium brachytherapy as ...
Source: Journal of Contemporary Brachytherapy - May 29, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Image-guided high-dose-rate intracavitary brachytherapy technique for nasal keloid - a case report.
In conclusion, HDR intracavitary brachytherapy is an effective way to prevent the recurrence of nasal keloids post-surgery.
PMID: 30038650 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 26, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Comparative study of concomitant chemoradiation versus concomitant chemoradiation followed by high-dose-rate intraluminal brachytherapy in locally advanced esophageal carcinoma: a single institutional study.
Conclusions: In our study, addition of brachytherapy as a boost following concurrent chemoradiation failed to improve treatment outcomes without additional toxicity in locally advanced esophageal cancer.
PMID: 30038642 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 26, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Initial experience using superflab as intravaginal packing during interstitial brachytherapy for advanced gynecologic cancer.
Conclusions: Our initial experience with superflab as vaginal packing demonstrates technical feasibility and dosimetric improvement for OAR.
PMID: 30038641 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 26, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Dosimetric evaluation of Point A and volume-based high-dose-rate plans: a single institution study on adaptive brachytherapy planning for cervical cancer.
Conclusions: Our study reports the relative improvement in OAR doses per HDR-BT fraction by HDRVOL planning compared to HDRPointA planning and demonstrates the dosimetric advantages of volume-based HDR-BT planning in creating more conformal plans.
PMID: 30038639 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 26, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy.
Conclusions: Dose escalation to MRSI-defined DIL is feasible. Toxicity was low but incompletely assessed due to limited patients' enrollment.
PMID: 30038638 [PubMed]
Source: Journal of Contemporary Brachytherapy - July 26, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Official Annual Meeting of Indian Brachytherapy Society8th ANNUAL CONFERENCE OF INDIAN BRACHYTHERAPY SOCIETY 2018 (IBSCON 2018) PROCEEDINGS.
Authors: Mummudi N, Gudi S, Bhalavat R, Mahantshetty U, Indian Brachytherapy Society
PMID: 30237822 [PubMed]
Source: Journal of Contemporary Brachytherapy - September 22, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.
Conclusions: Tumor factors in addition to radiation treatment may contribute to secondary effects. Enhanced clinical optimization should evaluate radiobiological doses delivered to the tumor volume and surrounding normal ocular structures.
PMID: 30237818 [PubMed]
Source: Journal of Contemporary Brachytherapy - September 22, 2018 Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
